John Nackel - Ensign Insider

EGB -- Germany Stock  

EUR 31.89  1.28  4.18%

  Director
Dr. John G. Nackel, Ph.D. is an Independent Director of The Ensign Group, Inc. Dr. Nackel has served as a member of our Board of Directors since his election to the Board in June 2008. He is currently the Chairman and Chief Executive Officer of ThreeSixty Advisory Group, LLC and Founder and General Partner of Wavemaker ThreeSixty Health, LP venture fund. Founded in 2007 by Dr. Nackel, ThreeSixty consults with leading health systems, payers, physicians, medical technology companies, and other providers. Founded in 2018, Wavemaker 360 invests in earlystage health care companies in the valuebased payment space. Dr. Nackel is a 25year veteran of Ernst Young where he advised health care companies in his role as a Global Managing Director of Health Care. Dr. Nackel also served as CEO of Ingenix Consulting, a division of United Healthcare
Age: 65  Director Since 2008      
949-487-9500  http://www.ensigngroup.net
Nackel served as a director of Mercury General Corporationrationrationration from 2016 until 2018. During his career, Dr. Nackel has also served as a board member or chairman of several privately held startups and emerging companies, including Visual Health Solutions, Vitalacy, HealthTask, ConnectedHealth, NetStrike, and Sertan, Inc. He earned his bachelor degree at Tufts University, master degrees in public health and industrial engineering at the University of Missouri, and a Ph.D. in industrial engineering at the University of Missouri. He is a fellow of the American College of Healthcare Executives and the Healthcare Information and Management Systems Society . He is a senior member of the Institute of Industrial Engineers . We believe that Dr

John Nackel Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.22 % which means that it generated profit of $6.22 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.43 % meaning that it generated $12.43 on every $100 dollars invested by stockholders.
The company has accumulated 290.48 M in total debt with debt to equity ratio (D/E) of 55.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. The Ensign Group has Current Ratio of 1.6 which is within standard range for the sector.

Similar Executives

Entity Summary

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses in the United States. The company was founded in 1999 and is based in Mission Viejo, California. Ensign operates under Long-Term Care Facilities classification in Germany and traded on Frankfurt Stock Exchange. It employs 21301 people.The Ensign Group (EGB) is traded on Frankfurt Stock Exchange in Germany. It is located in 27101 Puerta Real and employs 21,301 people.

The Ensign Group Leadership Team

Suzanne Snapper, CFO
Chad Keetch, Executive Vice President Secretary
Lee Daniels, Independent Director
Beverly Wittekind, Vice President General Counsel
Barry Smith, Independent Director
Daren Shaw, Independent Director
Malene Davis, Director
Barry Port, President of The Flagstone Group, Inc.
Roy Christensen, Chairman of the Board
John Nackel, Independent Director
Christopher Christensen, President CEO, Director
Antoinette Hubenette, Independent Director

Stock Performance Indicators

Did you try this?

Run CEO Directory Now
   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch CEO Directory

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Ensign and Steris Plc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.